Gary Jacob’s rise to CEO of a Nasdaq-listed biotech company started with chemistry classes in Benton Hall and a willingness to take risks and embrace change.
LATEST IN drug discovery
1969 alumnus’ journey to CEO of Synergy Pharmaceuticals, FDA-approved drug TRULANCE starts with UMSL chemistry degree
Gary Jacob’s rise to CEO of a Nasdaq-listed biotech company started with chemistry classes in Benton Hall and a willingness to take risks and embrace change.
1969 alumnus’ journey to CEO of Synergy Pharmaceuticals, FDA-approved drug TRULANCE starts with UMSL chemistry degree
Gary Jacob’s rise to CEO of a Nasdaq-listed biotech company started with chemistry classes in Benton Hall and a willingness to take risks and embrace change.
Whitney and Anna Harris Conservation Forum takes attendees on tour of seldom-seen cave ecosystems
About 150 people attended the 29th annual forum, which featured presentations from biologists Vona Kuczynska, Matthew Niemiller and Jut Wynne.
MORE IN drug discovery
LATEST NEWS
- Whitney and Anna Harris Conservation Forum takes attendees on tour of seldom-seen cave ecosystems
- Chancellor Kristin Sobolik honored by Girls Inc. of St. Louis
- Veterans Day ceremony highlights UMSL’s commitment to supporting student veterans
- Eye on UMSL: Swag prep
- Associate Professor Lindsay Athamanah receives Emerson’s Excellence in Teaching Award
- 12th annual International Business Case Competition draws talent from across the country
- UMSL Tritons weekly rewind
- UMSL esports program more than fun and games for players
- Bridge Program graduates and UMSL freshmen Kauthar Hammad, Taylor Moore and Marlo Shivers honored as Suggs Scholars
- UMSL, FOCUS St. Louis working together to grow leaders today and in the future
